Though Lupron was invented in 1973, its manufacturer got patent extensions in 1989 by offering a slow-release version. Drugmakers commonly use this tactic to extend their exclusive rights to sell a product.
Poor oversight of the 340B program has empowered hospitals and PBMs to exploit charity care to pad their own profits by capturing the savings intended for needy patients.
The federal government launched a probe into whether the nation's largest drug store chains — including Walgreens and CVS — have refused to dispense meds that can induce abortions after Roe v. Wade was overturned.